Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells

ACS Medicinal Chemistry Letters

Volumn 5, Issue 2, 2014, Pages 143-148

  Strong, Amy L ^a   Jiang, Quan ^b   Zhang, Qiang ^b   Zheng, Shilong ^b   Boue, Stephen M ^c   Elliott, Steven ^a   Burow, Matthew E ^a   Bunnell, Bruce A ^a   Wang, Guangdi ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

^c SOUTHERN REGIONAL RESEARCH CENTER   (United States)

Author keywords

BMSCs; Daidzein analogs; mesenchymal stem cells; osteogenesis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALKALINE PHOSPHATASE; DAIDZEIN; ENDOGLIN; ESTROGEN; GENISTEIN; HERMES ANTIGEN; OSTEOPONTIN; SOMATOMEDIN C; THY 1 ANTIGEN; TRANSCRIPTION FACTOR OSTERIX;

ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DESIGN; DRUG SYNTHESIS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 84894106939     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml400397k     Document Type: Article

References (23)

1. Barrett-Connor, E. The economic and human cost of osteoporotic fracture Am. J. Med. 1995, 98, 3S-8S
2. Foundation, N. O. In America's bone health: The state of osteoporosis and low bone mass in our nation; National Osteoporosis Foundation: Washington, DC, 2002.
3. Burge, R.; Dawson-Hughes, B.; Solomon, D.; Wong, J.; King, A.; Tosteson, A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J. Bone Miner. Res. 2007, 22 (3) 465-475 (Pubitemid 46797130)
4. Raisz, L. Pathogenesis of osteoporosis: concepts, conflicts, and prospects J. Clin. Invest. 2005, 115 (12) 3318-3325 (Pubitemid 43121814)
5. Riggs, B.; Kholsa, S.; Melton, L. I. A unitary model for involutional osteoporosis: estrogen deficiency causes both type 1 and type 2 osteoporosis in postemenopausal women and contributes to bone loss in aging men J. Bone Miner. Res. 2005, 13, 763-773
6. Seeman, E. Pathogenesis of bone fragility in women and men Lancet 2002, 359, 1841-1850 (Pubitemid 34607063)
7. Cranney, A.; Guyatt, G.; Griffith, L.; Wells, G.; Tugwell, P.; Rosen, C. The Osteoporosis Methodology Group, and The Osteoporosis Research Advisory Group. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr. Rev. 2002, 23 (4) 570-578
8. Black, D.; Bauer, D.; Schwartz, A.; Cummings, S.; Rosen, C. Continuing bisphosphonate treatment for osteoporosis-for whom and for how long? N. Engl. J. Med. 2012, 366 (22) 2051-2053
9. Fanti, P.; C, M.-F.; Geng, Z.; Schmidt, J.; Moris, P.; Cohen, D.; Malluche, H. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats Osteoporosis Int. 1998, 8, 274-281 (Pubitemid 28427078)
10. Picherit, C.; Coxam, V.; Bennetau-Pelissero, C.; Kati-Coulibaly, S.; Davicco, M.; Lebecque, P.; Barlet, J. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats J. Nutr. 2000, 130, 1675-1681 (Pubitemid 30451052)
11. Somjen, D.; Katzburg, S.; Kohen, F.; Gayer, B.; Livne, E. Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo J. Cell Biochem. 2008, 103 (6) 1826-1832 (Pubitemid 351501913)
12. Setchell, K.; Lydeking-Olsen, E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies Am. J. Clin. Nutr. 2003, 28 (3 Suppl) 593S-609S (Pubitemid 40012554)
13. Srivastava, K.; Tyagi, A.; Khan, K.; Dixit, M.; Lahiri, S.; Kumar, A.; Changkija, B.; Khan, M.; Nagar, G.; Yadav, D.; Maurya, R.; Singh, S.; Jain, G.; Wahajuddin; Trivedi, R.; Chattopadhyay, N.; Singh, D. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts boneanabolic action by preventing osteoblast apoptosis Phytomedicine 2013, 20 (6) 470-480
14. Yadav, D. K.; Gautam, A. K.; Kureel, J.; Srivastava, K.; Sahai, M.; Singh, D.; Chattopadhyay, N.; Maurya, R. Synthetic analogs of daidzein, having more potent osteoblast stimulating effect Bioorg. Med. Chem. Lett. 2011, 21, 677-8
15. Jiang, Q.; Payton-Stewart, F.; Elliott, S. Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells J. Med. Chem. 2010, 53 (16) 6153-6163
16. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.; Deng, J.; Behringer, R.; de Crombrugghe, B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 2002, 108, 17-29 (Pubitemid 34137009)
17. Zhang, C. C. K.; Huang, Y.; Lyons, J. P.; Zhou, X.; Sinha, K.; McCrea, P. D.; de Crombrugghe, B. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 6936-6941 (Pubitemid 351754508)
18. Yakar, S.; Rosen, C. J.; Beamer, W. G.; Ackert-Bicknell, C. L.; Wu, Y.; Liu, J.-L.; Ooi, G. T.; Setser, J.; Frystyk, J.; Boisclair, Y. R.; LeRoith, D. Circulating levels of IGF-1 directly regulate bone growth and density J. Clin. Invest. 2002, 110 (6) 771-781
19. Xian, L.; Wu, X.; Pang, L.; Lou, M.; Rosen, C.; Qiu, T.; Crane, J.; Frassica, F.; Zhang, L.; Rodriguez, J. P.; Jia, X.; Yakar, S.; Xuan, S.; Efstratiadis, A.; Wan, M.; Cao, X. Matrix IGF-1 regulates bone mass by activation of mTOR in mesenchymal stem cells Nat. Med. 2012, 18 (7) 1095-1101
20. Cho, Y.; Chung, S.; Cho, K.; Shin, H.; Kim, N.; Jang, K.-h.; Kang, S. A.; Choue, R.-w. Black bean (Rhynchosia molubilis, Yak-Kong) exerts a prominent estrogenic effect on the proliferation of human MG-63 osteoblastic cells. J. Nutr. 2002, 132 (614S), (abstract).
21. Dang, Z. C.; Lowik, C. Dose-dependent effects of phytoestrogens on bone Trends Endocrinol. Metab. 2005, 16 (5) 207-213 (Pubitemid 40853883)
22. De Wilde, A. C. C.; Lacroix, H., In vivo and ex vivo effects of an isoflavone-rich diet on bone formation in growing pigs. Ann. Nutr. Metab. 2001, 45 (227), (abstract).
23. Cusack, S. J. C.; Cashman, K. D. The effect of estrogen and selected phytoestrogens on cell viability and molecular markers of SaOS2 osteoblast-like activity. Ann. Nutr. Metab. 2001, 45 (228), abstract.